|
Market Cap (3-Jul) $8,006,598,144 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (19-Jun) 16,724,445 (4.94%) (48th) |
|
52w High $31.97 |
52w Low $17.03 |
P/E 56.82 |
EPS 0.14 |
TLX released this announcement to the ASX on 2 November 2020, 14:20. The announcement is marked as price sensitive, and is 3 page(s) in length and 244.19kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.062% short sold according to ASIC data. It was ranked the 447th most shorted stock on the ASX. It is now ranked as the 48th most shorted stock on the ASX with 4.944% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Strategic Licence and Partnership for Greater China Market | 2 November 2020, 14:20 |
| Trading Halt | 30 October 2020, 8:24 |
| App 4C and Activities Report for September 2020 Quarter | 30 October 2020, 8:23 |
| Licence Agmt with DKFZ for Image-Guided Prostate Surgery | 28 October 2020, 8:22 |
You must be logged in to post a reply.
Telix Pharmaceuticals 